Ipca Laboratories Ltd. (IPCALAB)

Date Range: 2026-03-22 to 2026-06-22 | Starting Capital: ₹100,000

Symbol-Specific Risk & Execution Parameters

These execution parameters have been optimized specifically for IPCALAB based on historical volatility, structural character, and friction constraints:

ATR Stop Distance (max_stop_atr): 1.50x ATR
Minimum Reward-to-Risk Ratio (min_reward_risk): 1.20R
Friction Buffer Target (friction_min_target_pct): 0.03%
Positional Holds Allowed (allow_positional_hold): True

Executive Summary

Summary table for IPCALAB Report
Attribute	Value
Rating	NEUTRAL
Conviction Score	60/100
Trend	Neutral / Bullish
Sector Rank	6/19
Suitable Horizon	Swing & Positional & Long-Term
Action	Wait for a clear directional breakout or regime change.

Model Backtest & Validation Summary

To validate the conviction score recommendations, the system ran historical simulation backtests for IPCALAB under institutional execution assumptions:

Summary table for IPCALAB Report
Metric	Out-of-Sample (OOS) Backtest Performance
Validation Date Range	`2026-03-22 to 2026-06-22`
Total Signals Executed	`0` trades
Historical Win Rate	`0.0%` (0W / 0L) <span style="font-size: 0.8rem; padding: 2px 6px; border-radius: 4px; background-color: #ef444420; color: #ef4444; font-weight: bold; margin-left: 6px;" aria-label="Low reliability: fewer than 10 trades">Exploratory</span>
Average Trade Expectancy	`₹0.00/trade`
Profit Factor / Sortino Ratio	`0.00 / 0.00`
Maximum Backtest Drawdown	`0.0%`
Net Strategy Return	`+0.00%`
Cost & Slippage Assumptions	`0.16% round-trip trading friction (0.05% slippage, 0.03% commission, taxes)`
Execution Sizing Rules	`₹1,000 risk target per trade, ATR-based stop sizing (max 1.5% cap)`
Validation Methodology	`Out-of-Sample (OOS) Walk-Forward Validated Parameters`

What Changed Since Previous Report?

Initial Run / Baseline: No previous report was found for this symbol to perform comparative validation. This report establishes the baseline parameters.

Actionable Trading Guidance

Direct Stock Setup Outlook

No active intraday setup detected for the next session.

⌥ Options Strategy Recommendation

Recommended Vehicle: Cash Equity

Reason: Highest risk-adjusted return (EV/Risk Ratio of -0.047) with consistent historical expectancy and zero options friction.

Volatility Dashboard: Realized Vol (RV): 32.2% | Implied Vol (IV): 33.5% | IV Rank: 41.4% | IV Percentile: 77.6%
Directional Probabilities: P(up): 10% | P(down): 10% | P(flat): 80%
Expected Return Distribution: Median: +1.06% (10th: -5.82%, 90th: +10.35%) | Expected Move: 0.00 ATR

Expected Value (EV) Payoff Matrix:

Summary table for IPCALAB Report
Strategy	Expected Value (EV)	Capital (Margin)	Expected Return on Margin	Risk	EV / Risk
Iron Condor	₹664.72	₹11,987.25	5.5%	₹263.18	2.526
Bull Put Spread	₹1733.76	₹17,980.88	9.6%	₹2647.98	0.655
Futures	₹-354.67	₹89,904.38	-0.4%	₹30384.36	-0.012
Cash Equity	₹-1478.47	₹599,362.52	-0.2%	₹31481.88	-0.047
Synthetic Future	₹-10822.52	₹89,904.38	-12.0%	₹24014.50	-0.451
Covered Call	₹-10826.65	₹599,362.52	-1.8%	₹24014.50	-0.451
Calendar Spread	₹-10866.65	₹17,980.88	-60.4%	₹24054.50	-0.452
Ratio Spread	₹-10866.65	₹59,936.25	-18.1%	₹24054.50	-0.452

Systematic Execution Plan (Generic Framework)

Stop Loss: 1.5 × ATR from entry
Profit Targets: Target 1 (1R) for 50% scale-out, trail remainder.

Expected Outcomes & Suitability

Expected 1 Month Outcome

Bullish: 10.1%
Neutral: 79.9%
Bearish: 10.1%

Expected Return Range

Median: +1.06%
25th percentile: -3.54%
75th percentile: +5.73%

Portfolio Suitability

Suitable For:

✓ Swing Traders
✓ Positional Traders
✓ Long-Term Growth Investors
✓ Low Volatility Portfolios

Not Suitable For:

✗ Income Investors

Sector & Regime Context

Sector: Healthcare
Sector Strength: 8.9/10
Relative Strength: +0.25% vs NIFTY
Sector Rank: 6 of 19 sectors
Structural Regime: RANGE
Tactical Setup Focus: Range Mean Reversion, Failed Breakout Reversal, Directional Change Overshoot, Bollinger Band Reversal, Volume Capitulation Reversal, PDH/PDL Breakout, Opening Gap Fade

Conviction Score Breakdown:

1. Technical Setups: +10.0 / 35 (No active setup, but daily price is in a strong uptrend (Close > 20 EMA > 50 SMA > 200 SMA))
2. Fundamentals: +20.0 / 25 (Steady business growth structure (Grade B))
3. Sector Context: +17.8 / 20 (Sector Strength: 8.9/10 (Healthcare))
4. Regime & Momentum: +11.7 / 20 (Daily candle close location: +1.7 pts (35% of range), Market in low-volatility/range regime RANGE: +5.0 pts, VIX is 13.5 (Low volatility/risk): +5.0 pts)

Conviction Rating System Matrix:

Summary table for IPCALAB Report
Score Range	Meaning
90 - 100	Strong Buy
75 - 89	Buy
60 - 74	Watchlist
40 - 59	Neutral
Below 40	Avoid

Fundamental Analysis & Annual Guidance

Valuation: Trailing P/E: 35.5 | Forward P/E: 26.5 | PEG Ratio: N/A | Price/Book: 4.99
Business Growth: Revenue YoY: 0.06% | Quarterly EPS: 3.42% | ROE: N/A
Risk & Dividend: Beta: 0.06 | Dividend Yield: 0.38% | Book Value: 317.89
Investment Grade: Grade B (Accumulate)
Recommendation: Business is growing steadily. Consider accumulating on technical pullbacks. High-stability defensive profile (Beta: 0.06).
Annual Entry Guidance: Do not chase breakouts. Accumulate gradually exclusively during market corrections or pullbacks to the 50-day and 200-day SMAs.
Annual Exit Guidance: Liquidate if earnings growth turns negative, or if the broader market regime turns structurally bearish (NIFTY loses 200 SMA).

Historical & Simulation Evidence

Model Validation: Capital Preservation (No Trades)

The system did not execute any trades during this backtest period. This is a valid risk-mitigation outcome: potential setups were systematically filtered out because they did not meet our strict expectation-to-risk constraints.

Data Status: Successfully analyzed 821514 minutes of price action.

Filtering Status: 6 potential setups detected but rejected by execution filters:

2 rejected by Extendedness/200 SMA filter.
4 rejected by Intraday Liquidity Filter (vol < threshold).